JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB207447

Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade

  • 20ul selling size
  • RabMAb
  • Advanced Validation
  • Recombinant
  • What is this?

Be the first to review this product! Submit a review

|

(8 Publications)

Rabbit Recombinant Monoclonal SMAD2 antibody. Suitable for ChIC/CUT&RUN-seq, IP, ChIP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Recombinant fragment - Human samples. Cited in 8 publications.

View Alternative Names

MADH2, MADR2, SMAD2, SMAD family member 2, SMAD 2, hSMAD2, JV18-1, Mad-related protein 2, Mothers against decapentaplegic homolog 2, hMAD-2, MAD homolog 2, Mothers against DPP homolog 2, MADH3, SMAD3, SMAD family member 3, SMAD 3, hSMAD3, JV15-2, Mothers against decapentaplegic homolog 3, MAD homolog 3, Mad3, Mothers against DPP homolog 3, hMAD-3

10 Images
Immunocytochemistry/ Immunofluorescence - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling Smad2 + Smad3 with ab207447 at 1/500 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing signal translocation from cytoplasm to nucleus after TGF-beta (10ng/ml, 1h) treatment in HeLa cells. PMID : 9006934. The nuclear counter stain is DAPI (blue).

Tubulin is detected with Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) secondary antibody at 1/1000 dilution (red).

The negative controls are as follows :

-ve control 1 : ab207447 at 1/500 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) secondary at 1/1000 dilution.

-ve control 2 : Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary at 1/1000 dilution.

Flow Cytometry (Intracellular) - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling Smad2 and Smad3with ab207447 at 1/500 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (Alexa Fluorr® 488) at 1/500 dilution was used as the secondary antibody.

Immunoprecipitation - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)
  • IP

Supplier Data

Immunoprecipitation - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)

Smad2 + Smad3 were immunoprecipitated from 1mg of HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab207447 at 1/40 dilution. Western blot was performed from the immunoprecipitate using ab207447 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : HeLa whole cell lysate 10μg (Input).

Lane 2 : ab207447 IP in HeLa whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab207447 in HeLa whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 5 seconds.

All lanes:

Immunoprecipitation - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (ab207447)

false

Immunoprecipitation - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)
  • IP

Lab

Immunoprecipitation - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)

ab207447 Immunoprecipitating Smad2 + Smad3 in human HeLa whole cell lysate . 2μg of capture antibody in 0.35mg lysate was used. 10μg of cell lysate was incubated with primary antibody at a dilution of 1/1000 and VeriBlot for IP Detection Reagent (HRP) ab131366 was used for detection at a dilution of 1/1000.

Lane 1 : HeLa (human cervix adenocarcinoma) whole cell lysate
Lane 2 : HeLa (human cervix adenocarcinoma) whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab207447 in HeLa (human cervix adenocarcinoma) whole cell lysate

Blocking buffer : 5% NFDM/TBST

Diluting buffer : 5% NFDM/TBST

Smad2 and Smad3 can be resolved using a lower percentage gel.

All lanes:

Immunoprecipitation - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (ab207447)

Observed band size: 58-62 kDa

false

Exposure time: 3min

ChIP - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)
  • ChIP

Supplier Data

ChIP - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)

Chromatin was prepared from HaCaT (Human keratinocyte cell line) cells treated with 7ng/ml TGF-β for 1h and non-treated according to the Abcam X-ChIP protocol. Cells were fixed with formaldehyde for 10 minutes. The ChIP was performed with 25μg of chromatin, 2μg of ab207447 (blue), and 20μl of Anti rabit IgG sepharose beads. 2μg of rabbit normal IgG was added to the beads control (yellow). The immunoprecipitated DNA was quantified by real time PCR (Sybr green approach).

The ChIP condition is designed against Smad2 refer to PMID : 18955504.

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)
  • WB

Supplier Data

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (ab207447) at 1/2000 dilution

All lanes:

Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 52 kDa

Observed band size: 58-62 kDa

false

Exposure time: 15s

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)
  • WB

Supplier Data

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1 : 2 seconds; Lane 2 : 15 seconds.

Human Smad2 fragment recombinant protein contains aa2-270 with His-Tag®. Human Smad3 fragment recombinant protein contains aa2-227 with His-Tag® and GST-tag.

All lanes:

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (ab207447) at 1/50000 dilution

Lane 1:

Recombinant protein fragment human Smad2 at 0.01 µg

Lane 2:

Recombinant protein fragment human Smad3 at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 52 kDa

Observed band size: 38 kDa,60 kDa

false

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)
  • WB

Supplier Data

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (ab207447) at 1/10000 dilution

Lane 1:

HeLa (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 10 µg

Lane 2:

K562 (Human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate at 10 µg

Lane 3:

A549 (Human lung carcinoma cell line) whole cell lysate at 10 µg

Lane 4:

Human fetal liver lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 52 kDa

Observed band size: 58-62 kDa

false

Exposure time: 3min

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)
  • WB

Supplier Data

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)

Blocking/Dilution buffer : 5% NFDM/TBST.

Smad2 and Smad3 can be resolved using a lower percentage gel.

All lanes:

Western blot - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (ab207447) at 1/10000 dilution

All lanes:

HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 52 kDa

Observed band size: 52 kDa,58-62 kDa

false

Exposure time: 30s

ChIC/CUT&RUN sequencing - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)
  • ChIC/CUT&RUN-seq

Lab

ChIC/CUT&RUN sequencing - Anti-Smad2 + Smad3 antibody [EPR19557] - ChIP Grade (AB207447)

ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 HaCaT (Human keratinocyte cell line) cells (treated with 7ng/ml TGF-β for 1h) and 5 µg of ab207447 [EPR19557]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

  • Carrier free

    Anti-Smad2 + Smad3 antibody [EPR19557] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19557

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, ICC/IF, ChIC/CUT&RUN-seq, ChIP, WB, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ChICCUTRUNseq" : {"fullname" : "ChIC/CUT&RUN sequencing", "shortname":"ChIC/CUT&RUN-seq"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ChIP" : {"fullname" : "ChIP", "shortname":"ChIP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ChICCUTRUNseq-species-checked": "testedAndGuaranteed", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/40", "IP-species-notes": "<p></p>", "ChIP-species-checked": "testedAndGuaranteed", "ChIP-species-dilution-info": "2 µg for 25 µg chromatin", "ChIP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/500", "FlowCytIntra-species-notes": "<p></p>" }, "Recombinant fragment - Human": { "ChICCUTRUNseq-species-checked": "notRecommended", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "ChIP-species-checked": "notRecommended", "ChIP-species-dilution-info": "", "ChIP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/50000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Smad2 and Smad3 are intracellular proteins tightly involved in the TGF-β signaling pathway. These proteins also known as mothers against decapentaplegic homolog 2 and 3 play an important role in transmitting signals from the cell surface to the nucleus. Smad2 has a molecular weight of approximately 58 kDa while Smad3 is about 52 kDa. They are expressed in various tissues throughout the body including heart skin and immune cells. Upon activation Smad2 and Smad3 undergo phosphorylation a modification that is important for their function as signal transducers.
Biological function summary

The functions of Smad2 and Smad3 are critical in mediating cellular processes such as proliferation differentiation and apoptosis. These proteins often form complexes specifically oligomeric structures with other Smad proteins like co-Smad4 to exert their regulatory roles. The Smad2/3 complexes control the transcription of specific genes in response to TGF-β stimuli influencing cellular responses in a context-dependent manner.

Pathways

Smad2 and Smad3 are central to the TGF-β signaling pathway one significant pathway that affects cellular growth and differentiation. These proteins interact with TGF-β receptors on the cell surface to become phosphorylated forming a complex with Smad4 which then translocates to the nucleus. In the nucleus this complex regulates gene expression. Both Smad2 and Smad3 also engage with other signaling pathways such as the MAPK pathway further influencing cell behavior and cooperating with proteins like ERK.

Smad2 and Smad3 have been linked to conditions like cancer and fibrosis. Dysregulation of Smad2/3 signaling often leads to unchecked cell proliferation a hallmark of tumorigenesis. In fibrosis excessive Smad2/3 activity contributes to tissue scarring due to increased extracellular matrix production. For instance their interaction with proteins like α-SMA (alpha-smooth muscle actin) in fibroblasts plays a role in cardiac and pulmonary fibrosis. Understanding their exact contribution provides insights into potential therapeutic targets for treating these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. Promotes TGFB1-mediated transcription of odontoblastic differentiation genes in dental papilla cells (By similarity). Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator. May act as a tumor suppressor in colorectal carcinoma (PubMed : 8752209).
See full target information SMAD2

Additional targets

SMAD3

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Cancers 14: PubMed36291907

2022

Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a.

Applications

Unspecified application

Species

Unspecified reactive species

Vishnu Suresh Babu,Anadi Bisht,Ashwin Mallipatna,Deepak Sa,Gagan Dudeja,Ramaraj Kannan,Rohit Shetty,Nilanjan Guha,Stephane Heymans,Arkasubhra Ghosh

Experimental and therapeutic medicine 22:1093 PubMed34504547

2021

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis.

Applications

Unspecified application

Species

Unspecified reactive species

Meng Pan,Miao Li,Mei Guo,Huiying Zhou,Hui Xu,Fengshu Zhao,Feng Mei,Rui Xue,Jun Dou

Nature communications 10:3882 PubMed31462641

2019

GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Shinji Matsumoto,Taku Yamamichi,Koei Shinzawa,Yuuya Kasahara,Satoshi Nojima,Takahiro Kodama,Satoshi Obika,Tetsuo Takehara,Eiichi Morii,Hiroomi Okuyama,Akira Kikuchi

eLife 8: PubMed31241461

2019

Neural crest-specific deletion of in mice leads to craniofacial abnormalities including cleft palate.

Applications

Unspecified application

Species

Unspecified reactive species

Dasan Mary Cibi,Masum M Mia,Shamini Guna Shekeran,Lim Sze Yun,Reddemma Sandireddy,Priyanka Gupta,Monalisa Hota,Lei Sun,Sujoy Ghosh,Manvendra K Singh

International journal of nanomedicine 14:3645-3667 PubMed31190817

2019

Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Yan,Xue-Qi Li,Jia-Lun Duan,Chun-Jie Bao,Yi-Nuo Cui,Zhan-Bo Su,Jia-Rui Xu,Qian Luo,Ming Chen,Ying Xie,Wan-Liang Lu

Bioscience reports 38: PubMed30049844

2018

Bleomycin-enhanced alternative splicing of fibroblast growth factor receptor 2 induces epithelial to mesenchymal transition in lung fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Kui-Jun Chen,Qing Li,Chang-Mei Weng,Zhao-Xia Duan,Dong-Dong Zhang,Zhi-Qiang Chen,Jing Chen,Jian-Min Wang

Nature communications 8:15870 PubMed28627514

2017

Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC.

Applications

Unspecified application

Species

Unspecified reactive species

Junchao Cai,Lishan Fang,Yongbo Huang,Rong Li,Xiaonan Xu,Zhihuang Hu,Le Zhang,Yi Yang,Xun Zhu,Heng Zhang,Jueheng Wu,Yan Huang,Jun Li,Musheng Zeng,Erwei Song,Yukai He,Li Zhang,Mengfeng Li

American journal of translational research 9:1193-1202 PubMed28386345

2017

TGF-β/MAPK signaling mediates the effects of bone marrow mesenchymal stem cells on urinary control and interstitial cystitis after urinary bladder transplantation.

Applications

Unspecified application

Species

Unspecified reactive species

Ya Xiao,Ya-Jun Song,Bo Song,Chi-Bing Huang,Qing Ling,Xiao Yu
View all publications
chicCutRunSequencingBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com